Figure 2.
Urinary TGF-β1 excretion increased in patients with crescentic nephritis (CN) (n = 15, p < 0.01) and with various types of proliferative GN (vGN) (n = 12, p < 0.05), compared to healthy subjects (n = 10).
Urinary TGF-β1 excretion increased in patients with crescentic nephritis (CN) (n = 15, p < 0.01) and with various types of proliferative GN (vGN) (n = 12, p < 0.05), compared to healthy subjects (n = 10).